Delic Teams Up With Paradigm To Create Ketamine Toxicology Testing Solution, Raises $7M For Expansion
Psychedelic wellness platform Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) announced Thursday a first of its kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St.